Sensus Healthcare, Inc. (SRTS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 4.33M USD | Liabilities, Current |
| Cash and equivalents | 15.19M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.68M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 18.46M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.33M | $15.19M | (m) | $1.68M | $18.46M | (m) |
| 2026-03-31 | (m) | $5.86M | $18.33M | (m) | $3.58M | $16.50M | (m) |
| 2025-12-31 | (m) | $4.72M | $22.08M | (m) | $6.04M | $14.56M | (m) |
| 2025-09-30 | (m) | $6.80M | $24.45M | (m) | $9.34M | $13.04M | (m) |
| 2025-06-30 | (m) | $6.41M | $22.16M | (m) | $12.62M | $12.40M | (m) |
| 2025-03-31 | (m) | $6.72M | $19.07M | (m) | $18.02M | $9.92M | (m) |
| 2024-12-31 | (m) | $5.88M | $22.06M | (m) | $19.73M | $10.10M | (m) |
| 2024-09-30 | (m) | $5.21M | $22.56M | (m) | $16.96M | $11.97M | (m) |
| 2024-06-30 | (m) | $4.68M | $18.97M | (m) | $18.29M | $12.77M | (m) |
| 2024-03-31 | (m) | $5.47M | $14.73M | (m) | $19.63M | $14.72M | (m) |
| 2023-12-31 | (m) | $4.21M | $23.15M | (m) | $10.64M | $11.86M | (m) |
| 2023-09-30 | (m) | $5.23M | $20.49M | (m) | $6.88M | $13.20M | (m) |
| 2023-06-30 | (m) | $5.19M | $20.05M | (m) | $9.15M | $10.13M | (m) |
| 2023-03-31 | (m) | $6.17M | $19.34M | (m) | $12.73M | $6.34M | (m) |
| 2022-12-31 | (m) | $7.70M | $25.52M | (m) | $17.30M | $3.50M | (m) |
| 2022-09-30 | (m) | $6.58M | $37.58M | (m) | $7.40M | $2.35M | (m) |
| 2022-06-30 | (m) | $10.18M | $33.70M | (m) | $10.31M | $1.69M | (m) |
| 2022-03-31 | (m) | $10.26M | $32.83M | (m) | $10.54M | $2.33M | (m) |
| 2021-12-31 | (m) | $5.96M | $14.52M | (m) | $12.13M | $1.76M | (m) |
| 2021-09-30 | (m) | $4.77M | $16.39M | (m) | $4.07M | $2.04M | (m) |
| 2021-06-30 | (m) | $5.15M | $15.20M | (m) | $4.58M | $3.13M | (m) |
| 2021-03-31 | (m) | $4.68M | $13.65M | (m) | $4.06M | $4.30M | (m) |
| 2020-12-31 | (m) | $4.86M | $14.91M | (m) | $3.78M | $4.43M | (m) |
| 2020-09-30 | (m) | $4.76M | $16.13M | (m) | $1.34M | $5.28M | (m) |
| 2020-06-30 | (m) | $4.80M | $18.41M | (m) | $1.09M | $5.46M | (m) |
| 2020-03-31 | (m) | $5.63M | $12.10M | (m) | $7.84M | $3.96M | (m) |
| 2019-12-31 | (m) | $6.47M | $8.10M | (m) | $14.01M | $3.00M | (m) |
| 2019-09-30 | (m) | $6.53M | $6.91M | (m) | $13.50M | $2.26M | (m) |
| 2019-06-30 | (m) | $6.03M | $11.43M | (m) | $12.22M | $2.10M | (m) |
| 2019-03-31 | (m) | $5.20M | $6.25M | (m) | $16.88M | $1.55M | (m) |
| 2018-12-31 | (m) | $6.02M | $12.48M | (m) | $13.15M | $1.63M | (m) |
| 2018-09-30 | (m) | $5.81M | $17.12M | (m) | $10.66M | $1.97M | (m) |
| 2018-06-30 | (m) | $4.95M | $8.01M | (m) | $8.05M | $1.57M | (m) |
| 2018-03-31 | (m) | $4.96M | $9.52M | (m) | $8.06M | $1.23M | (m) |
| 2017-12-31 | (m) | $4.87M | $10.09M | (m) | $4.96M | $1.17M | (m) |
| 2017-09-30 | (m) | $6.12M | $6.84M | (m) | $5.07M | $1.73M | (m) |
| 2017-06-30 | (m) | $5.96M | $4.22M | (m) | $4.78M | $1.56M | (m) |
| 2017-03-31 | (m) | $5.44M | $3.14M | (m) | $4.22M | $1.54M | (m) |
| 2016-12-31 | (m) | $3.66M | $5.04M | (m) | $3.10M | $1.25M | (m) |
| 2016-09-30 | (m) | $3.01M | $4.61M | (m) | $3.93M | $1.26M | (m) |
| 2016-06-30 | (m) | $5.65M | $15.76M | (m) | $2.54M | $1.04M | (m) |
| 2016-03-31 | (m) | (m) | $4.75M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $3.67M | $5.07M | (m) | $2.07M | $998.86K | (m) |
| 2015-09-30 | (m) | (m) | $3.43M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $3.88M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $4.54M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |